title: Tripeptide mimetics inhibit the 20 S proteasome by covalent bonding to the active threonines.
abstract: Proteasomes play an important role in protein turnover in living cells. The inhibition of proteasomes affects cell cycle processes and induces apoptosis. Thus, 20 S proteasomal inhibitors are potential tools for the modulation of neoplastic growth. Based on MG132, a potent but nonspecific 20 S proteasome inhibitor, we designed and synthesized 22 compounds and evaluated them for the inhibition of proteasomes. The majority of the synthesized compounds reduced the hydrolysis of LLVY-7-aminomethylcoumarin peptide substrate in cell lysates, some of them drastically. Several compounds displayed inhibitory effects when tested in vitro on isolated 20 S proteasomes, with lowest IC(50) values of 58 nm (chymotrypsin-like activity), 53 nm (trypsin-like activity), and 100 nm (caspase-like activity). Compounds 16, 21, 22, and 28 affected the chymotrypsin-like activity of the beta5 subunit exclusively, whereas compounds 7 and 8 inhibited the beta2 trypsin-like active site selectively. Compounds 13 and 15 inhibited all three proteolytic activities. Compound 15 was shown to interact with the active site by x-ray crystallography. The potential of these novel inhibitors was assessed by cellular tolerance and biological response. HeLa cells tolerated up to 1 microm concentrations of all substances. Intracellular reduction of proteasomal activity and accumulation of polyubiquitinated proteins were observed for compounds 7, 13, 15, 22, 25, 26, 27, and 28 on HeLa cells. Four of these compounds (7, 15, 26, and 28) induced apoptosis in HeLa cells and thus are considered as promising leads for anti-tumor drug development.
authors.affiliation: Darmstadt University of Technology, Clemens Schöpf-Institute for Organic Chemistry and Biochemistry, D-64287 Darmstadt, Germany.
authors.forename: Hannes A
authors.initials: HA
authors.lastname: Braun
authors.forename: Sumaira
authors.initials: S
authors.lastname: Umbreen
authors.forename: Michael
authors.initials: M
authors.lastname: Groll
authors.forename: Ulrike
authors.initials: U
authors.lastname: Kuckelkorn
authors.forename: Izabela
authors.initials: I
authors.lastname: Mlynarczuk
authors.forename: Moritz E
authors.initials: ME
authors.lastname: Wigand
authors.forename: Ilse
authors.initials: I
authors.lastname: Drung
authors.forename: Peter-Michael
authors.initials: PM
authors.lastname: Kloetzel
authors.forename: Boris
authors.initials: B
authors.lastname: Schmidt
mesh_terms: D001665:Binding Sites; D018360:Crystallography, X-Ray; D004912:Erythrocytes / Q000201:enzymology; D006801:Humans; D007700:Kinetics; D008958:Models, Molecular; D009842:Oligopeptides / Q000494:pharmacology*; D046988:Proteasome Endopeptidase Complex / Q000097:blood / Q000737:chemistry; D061988:Proteasome Inhibitors; D011487:Protein Conformation; D013912:Threonine
chemical_list: D009842:Oligopeptides; D061988:Proteasome Inhibitors; D013912:Threonine; D046988:Proteasome Endopeptidase Complex